Annual Drug Patent Expirations for ZUBSOLV
Zubsolv is a drug marketed by Orexo Us Inc and is included in one NDA. There are five patents protecting this drug and four Paragraph IV challenges.
Drug patent litigation for ZUBSOLV.
This drug has forty patent family members in twenty-eight countries.
The generic ingredient in ZUBSOLV is buprenorphine hydrochloride; naloxone hydrochloride. Additional details are available on the buprenorphine hydrochloride; naloxone hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
